Exenatide therapy in insulin-treated type 2 diabetes and obesity

QJM : Monthly Journal of the Association of Physicians
U A NayakB M Singh

Abstract

Exenatide, a GLP-1 analogue, is used in combination with oral anti-diabetic agents in type 2 diabetes and obesity, and promotes weight loss. Exenatide use in combination with insulin in insulin-treated type 2 diabetes and obesity is unlicensed in the UK and outcomes are unclear. To assess the effectiveness of exenatide in insulin-treated type 2 diabetes with obesity. This prospective study included 174 consecutive patients with insulin-treated type 2 diabetes and obesity initiated on exenatide in our out-patient, between October 2007 and November 2008. Weight, BMI, HbA1c, serum fructosamine, total cholesterol, HDL-cholesterol and insulin doses were recorded at baseline, 3, 6 and 12 months. Side effect profiles were recorded. Fourteen patients discontinued exenatide before 3 months of initiation, because of side effects, and were excluded. Data were analysed on remaining 160 people all of whom completed 6 months and 57 completed 12 months treatment. Mean weight loss was 10.7 +/- 5.7 kg and 12.8 +/- 7.5 kg (P < 0.001) at 6 and 12 months. Insulin doses dropped significantly (mean 144 +/- 90 U/day at baseline to 51 +/- 55 U/day and 55 +/- 53 U/day at 6 and 12 months). At 3 months, 25% came off insulin. There was little change in Hb...Continue Reading

References

Sep 22, 2000·Annals of Surgery·P R SchauerJ Luketich
Jul 5, 2003·The Journal of Clinical Endocrinology and Metabolism·Orville G KoltermanAlain D Baron
Oct 8, 2003·Annals of Surgery·Philip R SchauerDavid Kelley
Oct 28, 2003·Diabetes Care·Matthew C RiddleUNKNOWN Insulin Glargine 4002 Study Investigators
Feb 19, 2004·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·S O'MearaG ter Riet
Oct 14, 2004·JAMA : the Journal of the American Medical Association·Henry BuchwaldKaren Schoelles
Apr 6, 2005·Annals of Internal Medicine·Zhaoping LiSally C Morton
Dec 6, 2006·The New England Journal of Medicine·Steven E KahnUNKNOWN ADOPT Study Group
Sep 18, 2007·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Prabhakar ViswanathanParesh Dandona
May 9, 2008·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Catherine A SheffieldRobert A Hamilton
May 23, 2009·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Brian E KaderaEric J DeMaria

❮ Previous
Next ❯

Citations

Jun 30, 2011·Diabetes Technology & Therapeutics·Riccardo Perfetti
Aug 1, 2012·Diabetes Technology & Therapeutics·Krystal L EdwardsBrian K Irons
Jun 1, 2012·Diabetes, Obesity & Metabolism·J J Holst, T Vilsbøll
Jun 17, 2015·Expert Opinion on Pharmacotherapy·Carla Francés ArtigasMichael J Theodorakis
Aug 11, 2010·Pharmaceuticals·Angelos Kyriacou, Abu Baker Ahmed
Jul 18, 2012·Expert Opinion on Investigational Drugs·Johan JendleZvonko Milicevic
Jan 6, 2012·Current Medical Research and Opinion·Philip LevinOnur Baser
Aug 27, 2011·Current Medical Research and Opinion·Scott E Nelson
Oct 11, 2013·Current Medical Research and Opinion·Ronald Goldenberg
Nov 26, 2015·International Journal of Clinical Pharmacy·Stefanie Amarens de BoerKlaas Hoogenberg
Sep 18, 2013·The Journal of Nutritional Biochemistry·Frank A DucaMihai Covasa
Jan 3, 2012·Medicina clínica·Pedro Pujante AlarcónJavier Tébar Massó
May 2, 2012·Annals of the New York Academy of Sciences·Liza K Phillips, Johannes B Prins
Sep 28, 2014·Expert Opinion on Pharmacotherapy·Eva W IepsenJens J Holst
Aug 23, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Irl B HirschBrian Calingaert
Mar 21, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Guillermo E Umpierrez, Luigi Meneghini
Jul 12, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Philip A LevinLee A Bromberger
Aug 19, 2014·Journal of Diabetes and Its Complications·Bernard CharbonnelMelanie Davies
Nov 9, 2016·Endocrinology and Metabolism Clinics of North America·Alissa R SegalRichard S Beaser
Jul 3, 2015·Therapeutic Advances in Endocrinology and Metabolism·Sri Harsha Tella, Marc S Rendell
Nov 1, 2014·Expert Review of Endocrinology & Metabolism·Daisuke Yabe, Yutaka Seino
Jun 7, 2019·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Janelle B GyorffyMark W True

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.